Dabigatran Etexilate iMpurity I

Dabigatran Etexilate iMpurity I Suppliers list
Company Name: career henan chemical co
Tel: +86-0371-86658258 +8613203830695
Email: sales@coreychem.com
Products Intro: Product Name: Dabigatran Etexilate iMpurity I
CAS:255706-13-9
Purity:99% Package:1KG;7USD
Company Name: Standardpharm Co. Ltd.
Tel: 86-714-3992388
Email: overseasales1@yongstandards.com
Products Intro: Product Name:Dabigatran Impurity 28
CAS:255706-13-9
Purity:0.99 Package:10mg;25mg;50mg;100mg
Company Name: Hefei TNJ Chemical Industry Co.,Ltd.
Tel: +86-0551-65418684 +8618949823763
Email: sales@tnjchem.com
Products Intro: Product Name:Hexyl ((4-aminophenyl)(imino)methyl)carbamate
CAS:255706-13-9
Company Name: China National Standard Pharmaceutical Corporation Limited
Tel: +8615391658522
Email: overseasales@yongstandards.com
Products Intro: Product Name:Dabigatran Impurity 28
CAS:255706-13-9
Purity:0.95 Package:Vials
Company Name: Chongqing Chemdad Co., Ltd
Tel: +86-023-6139-8061 +86-86-13650506873
Email: sales@chemdad.com
Products Intro: Product Name:Dabigatran Etexilate iMpurity I
CAS:255706-13-9
Purity:0.98 Package:1kg,2kg,5kg,10kg,25kg

Dabigatran Etexilate iMpurity I manufacturers

Dabigatran Etexilate iMpurity I Basic information
Product Name:Dabigatran Etexilate iMpurity I
Synonyms:Dabigatran Etexilate iMpurity I;hexyl (E)-(amino(4- aminophenyl)methylene)carbamate;Dabigatran Impurity 28;Carbamic acid, N-[(4-aminophenyl)iminomethyl]-, hexyl ester;Dabigatran JPBA Impurity 4;Hexyl N-[(4-aminophenyl)iminomethyl]carbamate;Des-(ethyl 3-(N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate Dabigatran Etexilate;Dabigatran etexilate impurity181
CAS:255706-13-9
MF:C14H21N3O2
MW:263.34
EINECS:
Product Categories:
Mol File:255706-13-9.mol
Dabigatran Etexilate iMpurity I Structure
Dabigatran Etexilate iMpurity I Chemical Properties
density 1.14±0.1 g/cm3(Predicted)
pka9.79±0.46(Predicted)
Safety Information
MSDS Information
Dabigatran Etexilate iMpurity I Usage And Synthesis
UsesDes-(ethyl 3-(N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate Dabigatran Etexilate is the impurity of Dabigatran (D100090), which is a nonpeptide, direct thrombin inhibitor and is antithrombotic.
Dabigatran Etexilate iMpurity I Preparation Products And Raw materials
Raw materialsHEXYL CHLOROFORMATE-->4-Aminobenzamidine dihydrochloride
Tag:Dabigatran Etexilate iMpurity I(255706-13-9) Related Product Information
Dabigatran iMpurity L Des-(N-2-pyridyl-β-alanine Ethyl Ester) Dabigatran Etexilate 5-Ethyl Carboxylate (Dabigatran IMpurity) N-(4-cyanophenyl)-2-((4-cyanophenyl)amino)acetamide Dabigatran Impurity 9 Dabigatran Etexilate iMpurity G (E/Z)-FK-506 26,28-Allylic Ester RearrangeMent IMpurity 15,19-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone,3-[(1E)-2-[(1R,3R,4R)-3,4-dihydroxycyclohexyl]-1-methylethenyl]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propen-1-yl)-,(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)- 19-Epi FK-506 Dabigatran etexilate 9-hydroxy-2-methyl-3-vinyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one Dabigatran Etexilate iMpurity O Alogliptin Imp.11 Ezetimibe impurity 3 Alogliptin Imp.12 Dabigatran Etexilate iMpurity K N-METHYLBARBITURIC ACID Dabigatran Etexilate iMpurity J (R)-N-(1-(naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl) -N-(3-(3-(trifluoromethyl)phenyl)propyl)propan-1-amine hydrochloride

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.